High-sensitivity cardiac troponin t predicts nondipper hypertension in newly diagnosed hypertensive patients

Journal of Clinical Hypertension

Volumn 15, Issue 10, 2013, Pages 731-736

  Çayli, Murat ^a   Gür, Mustafa ^a   Elbasan, Zafer ^a   Şeker, Taner ^a   Türkoǧlu, Caner ^a   Kaypakli, Onur ^a   Şahin, Durmuş Y ^a   Uçar, Hakan ^a   Kivrak, Ali ^a   Koyunsever, Nermin Y ^a   Şen, Ömer ^a  

^a Adana Numune Training and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC;

BIOLOGICAL MARKERS; CIRCADIAN RHYTHM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TROPONIN T;

EID: 84884986823     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12176     Document Type: Article

References (27)

1. O'Brien ET, Murphy J, Tyndall A, et al. Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. J Hypertens. 1991;9:355-360.
2. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension: systolic hypertension in Europe trial investigators. JAMA. 1999;282:539-546.
3. Krause T, Lovibond K, Caulfield M, et al; Guideline Development Group. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891.
4. Verdecchia P, Schillaci G, Porcellati C. Dippers versus non-dippers. J Hypertens. 1991;9:42-48.
5. Higashi Y, Nakagawa K, Kimura M, et al. Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. J Am Coll Cardiol. 2002;40:239-243.
6. Syrseloudis D, Tsioufis C, Aragiannis D, et al. The dominant role of the systolic component of nondipping status on target-organ damage in never-treated hypertensives. Am J Hypertens. 2011;24:292-298.
7. Cicek Y, Durakoglugil ME, Kocaman SA, et al. Non-dipping pattern in untreated hypertensive patients is related to increased pulse wave velocity independent of raised nocturnal blood pressure. Blood Press. 2013;22:34-38.
8. Erden M, Kocaman SA, Poyraz F, et al. Incremental effects of serum uric acid levels, autonomic dysfunction, and low-grade inflammation on nocturnal blood pressure in untreated hypertensive patients and normotensive individuals. Turk Kardiyol Dern Ars. 2011;39:531-539.
9. Gür M, Elbasan Z, Şahin DY, et al. DNA damage and oxidative status in newly diagnosed, untreated, dipper and non-dipper hypertensive patients. Hypertens Res. 2013;36:166-171.
10. Ohkubo T, Imai Y, Tsuji I, et al. Relation between nocturnal decline in blood pressure and mortality, the Ohasama Study. Am J Hypertens. 1997;10:1201-1207.
11. Sato Y, Yamamoto E, Sawa T, et al. High-sensitivity cardiac troponin T in essential hypertension. J Cardiol. 2011;58:226-231.
12. de Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010;304:2503-2512.
13. Hellemons ME, Lambers Heerspink HJ, Gansevoort RT, et al. High-sensitivity troponin T predicts worsening of albuminuria in hypertension; results of a nested case-control study with confirmation in diabetes. J Hypertens. 2013;31:805-812.
14. Stergiou GS, Salgami EV; World Health Organization-International Society of Hypertension (WHO-ISH), USA Joint National Committee on Prevention, Detection, Evalutiaon, Treatment of High Blood Pressure (JNC-7), European Society of Hypertension-European Society of Cardiology (ESH-ESC). New European, American and International guidelines for hypertension management: agreement and disagreement. Expert Rev Cardiovasc Ther. 2004;2:359-368.
15. Hoshide S, Fukutomi M, Eguchi K, et al. clinical and change in high-sensitive cardiac troponin T on hypertensive treatment. Clin Exp Hypertens. 2013;35:40-44.
16. Lang RM, Bierig M, Devereux RB, et al; Chamber Quantification Writing Group. Recommendations for Chamber Quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
17. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
18. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man, anatomic validation of the method. Circulation. 1977;55:613-618.
19. Melander O, Newton-Cheh C, Almgren P, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA. 2009;302:49-57.
20. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830-840.
21. Hickman PE, Potter JM, Aroney C, et al. Cardiac troponin may be released by ischemia alone, without necrosis. Clin Chim Acta. 2010;411:318-323.
22. Fortũno MA, Ravassa S, Fortũno A, et al. Cardiomyocyte apoptotic cell death in arterial hypertension: mechanisms and potential management. Hypertension. 2001;38:1406.
23. Dogan SM, Aydin M, Gursurer M, et al. N-terminal probrain natriuretic peptide predicts altered circadian variation in essential hypertension. Coron Artery Dis. 2007;18:347-352.
24. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321-328.
25. Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis. 2002;44:293-321.
26. Rubin J, Matsushita K, Ballantyne CM, et al. Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol. 2012;59:484-489.
27. Yiu KH, Zhao CT, Chen Y, et al. Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2013;12:94.